IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,748,464 | -12.8% | 1,219,986 | -3.6% | 0.00% | 0.0% |
| Q2 2023 | $13,465,601 | +1.1% | 1,265,564 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,317,826 | -15.1% | 1,265,953 | -0.1% | 0.00% | -25.0% |
| Q4 2022 | $15,693,496 | -7.5% | 1,266,626 | -22.6% | 0.00% | 0.0% |
| Q3 2022 | $16,957,000 | -11.7% | 1,636,872 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $19,209,000 | +42.1% | 1,666,065 | +55.0% | 0.00% | +33.3% |
| Q1 2022 | $13,518,000 | +31.7% | 1,074,549 | +22.1% | 0.00% | +50.0% |
| Q4 2021 | $10,264,000 | -0.9% | 880,288 | +11.0% | 0.00% | 0.0% |
| Q3 2021 | $10,358,000 | -1.8% | 793,076 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $10,547,000 | -5.3% | 819,452 | -17.7% | 0.00% | 0.0% |
| Q1 2021 | $11,133,000 | +20.5% | 995,830 | +22.7% | 0.00% | 0.0% |
| Q4 2020 | $9,241,000 | +57.6% | 811,376 | +24.5% | 0.00% | +100.0% |
| Q3 2020 | $5,863,000 | -15.0% | 651,833 | -2.5% | 0.00% | -50.0% |
| Q2 2020 | $6,898,000 | +5.0% | 668,456 | +2.7% | 0.00% | 0.0% |
| Q1 2020 | $6,570,000 | -27.4% | 651,157 | -4.3% | 0.00% | 0.0% |
| Q4 2019 | $9,054,000 | +58.4% | 680,185 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $5,716,000 | -19.6% | 665,894 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $7,112,000 | -13.1% | 650,112 | +7.4% | 0.00% | 0.0% |
| Q1 2019 | $8,187,000 | +29.4% | 605,097 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $6,327,000 | -45.3% | 610,753 | -2.5% | 0.00% | -33.3% |
| Q3 2018 | $11,564,000 | -1.8% | 626,367 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $11,772,000 | +22.1% | 615,650 | -1.4% | 0.00% | 0.0% |
| Q1 2018 | $9,639,000 | +3.8% | 624,695 | +0.8% | 0.00% | +50.0% |
| Q4 2017 | $9,288,000 | -5.7% | 619,553 | -0.8% | 0.00% | -33.3% |
| Q3 2017 | $9,849,000 | -15.9% | 624,599 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $11,716,000 | +11.2% | 620,493 | +0.5% | 0.00% | 0.0% |
| Q1 2017 | $10,538,000 | +12.8% | 617,647 | +1.1% | 0.00% | 0.0% |
| Q4 2016 | $9,343,000 | +1.2% | 611,082 | +5.1% | 0.00% | 0.0% |
| Q3 2016 | $9,231,000 | +18.5% | 581,227 | -2.5% | 0.00% | +50.0% |
| Q2 2016 | $7,792,000 | +21.4% | 595,939 | +1.6% | 0.00% | 0.0% |
| Q1 2016 | $6,418,000 | -7.3% | 586,646 | -1.8% | 0.00% | 0.0% |
| Q4 2015 | $6,921,000 | +11.7% | 597,171 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $6,198,000 | -25.6% | 594,786 | -13.9% | 0.00% | 0.0% |
| Q2 2015 | $8,334,000 | -20.7% | 691,079 | +5.2% | 0.00% | -33.3% |
| Q1 2015 | $10,506,000 | +7.4% | 656,642 | +2.9% | 0.00% | 0.0% |
| Q4 2014 | $9,780,000 | +24.4% | 638,339 | +5.2% | 0.00% | +50.0% |
| Q3 2014 | $7,859,000 | -55.3% | 606,627 | -47.1% | 0.00% | 0.0% |
| Q2 2014 | $17,578,000 | +161.6% | 1,146,596 | +110.2% | 0.00% | 0.0% |
| Q1 2014 | $6,720,000 | +16.3% | 545,501 | +9.6% | 0.00% | 0.0% |
| Q4 2013 | $5,779,000 | -49.8% | 497,791 | -48.8% | 0.00% | 0.0% |
| Q3 2013 | $11,506,000 | +157.2% | 971,802 | +115.8% | 0.00% | +100.0% |
| Q2 2013 | $4,473,000 | – | 450,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |